F-group (family)
11.1.1.37 E1_DerP2_DerF2
Ligands and drugs
202
Member domains
71
with ligand contacts (≤ 4 Å)
35.1% of members
66
with DrugDomain annotations
32.7% of members
56
with a DrugBank compound
27.7% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 11.1.1.37 belongs to X-group 11 Immunoglobulin-like beta-sandwich, which binds 8.0 ligand superclasses per 20 proteins, broader than 58% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00141 | NAG | N-Acetylglucosamine | 30 |
| DB08231 | MYR | Myristic acid | 10 |
| DB03017 | DAO | Lauric acid | 8 |
| DB04038 | ERG | Ergosterol | 5 |
| DB01990 | C3S | Cholesterol sulfate | 4 |
| DB04933 | E55 | Eritoran | 4 |
| DB02261 | PFS | Platelet Activating Factor | 3 |
| DB03633 | LPE | Lpc-Ether | 3 |
| DB02767 | FTT | (R)-3-hydroxytetradecanoic acid | 2 |
| DB04660 | CH5 | Choline alfoscerate | 2 |
| DB00295 | — | Morphine | 1 |
| DB03548 | KDO | 3-deoxy-alpha-D-manno-oct-2-ulopyranosonic acid | 1 |
| DB04540 | CLR | Cholesterol | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| NAG | 2-acetamido-2-deoxy-beta-D-glucopyranose | 36 |
| MYR | MYRISTIC ACID | 10 |
| DAO | LAURIC ACID | 8 |
| 2IL | (3R)-3-(dodecanoyloxy)tetradecanoic acid | 6 |
| CL | CHLORIDE ION | 6 |
| OLA | OLEIC ACID | 6 |
| PGT | (1S)-2-{[{[(2R)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PALMITOYLOXY)METHYL]ETHYL STEARATE | 6 |
| ERG | ERGOSTEROL | 5 |
| LP3 | (7R)-4,7-DIHYDROXY-N,N,N-TRIMETHYL-10-OXO-3,5,9-TRIOXA-4-PHOSPHAHEPTACOSAN-1-AMINIUM 4-OXIDE | 5 |
| LP4 | 2-deoxy-3-O-[(3R)-3-hydroxytetradecanoyl]-2-{[(3R)-3-hydroxytetradecanoyl]amino}-4-O-phosphono-beta-D-glucopyranose | 5 |
| LP5 | (R)-((2R,3S,4R,5R,6R)-3-HYDROXY-2-(HYDROXYMETHYL)-5-((R)-3-HYDROXYTETRADECANAMIDO)-6-(PHOSPHONOOXY)TETRAHYDRO-2H-PYRAN-4-YL) 3-HYDROXYTETRADECANOATE | 5 |
| 0IL | (3R)-3-(tetradecanoyloxy)tetradecanoic acid | 4 |
| BEN | BENZAMIDINE | 4 |
| C3S | CHOLEST-5-EN-3-YL HYDROGEN SULFATE | 4 |
| E55 | 3-O-DECYL-2-DEOXY-6-O-{2-DEOXY-3-O-[(3R)-3-METHOXYDECYL]-6-O-METHYL-2-[(11Z)-OCTADEC-11-ENOYLAMINO]-4-O-PHOSPHONO-BETA-D-GLUCOPYRANOSYL}-2-[(3-OXOTETRADECANOYL)AMINO]-1-O-PHOSPHONO-ALPHA-D-GLUCOPYRANOSE | 4 |
| L9R | (2S)-3-(octadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate | 4 |
| LPE | 1-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOCHOLINE | 3 |
| PFS | (2R)-2-(acetyloxy)-3-(hexadecyloxy)propyl 2-(trimethylammonio)ethyl phosphate | 3 |
| A1L01 | (3~{S})-3-decanoyloxytetradecanoic acid | 2 |
| CH5 | 2-(((R)-2,3-DIHYDROXYPROPYL)PHOSPHORYLOXY)-N,N,N-TRIMETHYLETHANAMINIUM | 2 |